All Updates

All Updates

icon
Filter
Partnerships
Illumina joins forces with Breast Cancer Canada and AstraZeneca Canada to advance breast cancer screening and detection
Precision Medicine
Jun 15, 2023
This week:
Product updates
Meta introduces Meta Credits digital currency for Horizon Worlds
Metaverse Platforms
Today
Product updates
Liquid AI launches STAR framework for AI model architecture optimization
Foundation Models
Today
Funding
9fin raises USD 50 million in Series B funding to expand US operations
Capital Markets Tech
Yesterday
Partnerships
Shastic partners with MeridianLink to provide AI workflow automation for financial institutions
Workflow Automation Platforms
Yesterday
Funding
KisoJi Biotechnology raises CAD 41 million to develop oncology candidate
AI Drug Discovery
Yesterday
M&A
Deel acquires UK money transfer startup Atlantic Money for undisclosed sum
Remote Work Infrastructure
Yesterday
Funding
Acorai raises EUR 4.2 million in funding to advance clinical studies
Next-gen Medical Devices
Yesterday
Product updates
Bosch announces Light Drive, an AR solution for all-day smart glasses
Extended Reality
Yesterday
Product updates
Partnerships
Vuzix expands OSHA collaboration; launches upgraded M400 AR smart glasses
Extended Reality
Yesterday
Product updates
StrikerVR launches pre-orders for consumer-facing Mavrik haptic VR gun
Extended Reality
Yesterday
Precision Medicine

Precision Medicine

Jun 15, 2023

Illumina joins forces with Breast Cancer Canada and AstraZeneca Canada to advance breast cancer screening and detection

Partnerships

  • Breast Cancer Canada, AstraZeneca Canada, and Illumina have announced a research grant collaboration to advance breast cancer screening and detection using precision diagnostics and AI technology.

  • The primary goal of this partnership is to support Canadian research teams in their efforts to develop innovative screening and analysis techniques for breast cancer detection. Ilumina will support the collaboration by providing sequencing consumables. 

  • The collaboration aims to allocate CAD 200,000 (USD 151,381) in grants to selected projects that focus on leveraging precision or personalized technology, such as blood tests, imaging, and machine learning, to enhance accuracy and accessibility.

  • The projects that will be selected for funding will cover various aspects of precision oncology research and must include an AI component and participation from patient advocates. The submission period for research proposals will begin on July 3, 2023.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.